Efimov V A, Mirskikh O V, Chakhmakhcheva O G, Ovchinnikov Iu A
Bioorg Khim. 1985 May;11(5):621-7.
A procedure has been designed for changing specific nucleotides in a DNA sequence with efficiency. The method involves the use of the specially constructed cloning vectors pBRS1, pHS1, and pHS2. These plasmids are derivatives of pBR322 in which the EcoRI-HindIII region has been replaced by synthetic duplexes carrying SmaI, HpaI and XhoI sites, in addition to EcoRI and HindIII sites. The DNA fragment to be mutagenized is cloned in pHS1 (or pBRS1, or pHS2) using restriction sites close to the SmaI and HpaI sites. The recombinant plasmid obtained is digested with one of these enzymes to produce double-stranded DNA with blunt ends. This linear DNA is a substrate for exonuclease III (or T4 DNA polymerase). The digestion under controlled conditions produces duplex with protruding single-stranded 5'-regions which include the site of the desired mutation. The synthesis of DNA by DNA-polymerase I (Klenow's fragment), primed in part by the synthetic oligonucleotide containing the desired mutation, leads to the linear heteroduplex. The closed circular heteroduplex is formed by ligation. After transformation into E. coli, DNA replication generates homoduplexes, some of which contain the mutation. Colony hybridization with the same 32P-labeled oligonucleotide is used to select mutants. The yield of the mutants is 10-20%. This technique can be extended to replicative form of M13 vectors. It can be also applied to any DNA sequence which has a unique site of restriction endonuclease generating blunt ends.
已经设计出一种高效改变DNA序列中特定核苷酸的方法。该方法涉及使用特殊构建的克隆载体pBRS1、pHS1和pHS2。这些质粒是pBR322的衍生物,其中EcoRI - HindIII区域已被携带SmaI、HpaI和XhoI位点以及EcoRI和HindIII位点的合成双链体所取代。将要诱变的DNA片段利用靠近SmaI和HpaI位点的限制性位点克隆到pHS1(或pBRS1或pHS2)中。获得的重组质粒用这些酶之一消化以产生平端双链DNA。这种线性DNA是核酸外切酶III(或T4 DNA聚合酶)的底物。在受控条件下的消化产生具有突出单链5'区域的双链体,其中包括所需突变的位点。由DNA聚合酶I(Klenow片段)进行的DNA合成,部分由含有所需突变的合成寡核苷酸引发,导致形成线性异源双链体。通过连接形成闭环异源双链体。转化到大肠杆菌后,DNA复制产生同源双链体,其中一些含有突变。用相同的32P标记的寡核苷酸进行菌落杂交以选择突变体。突变体的产率为10 - 20%。该技术可以扩展到M13载体的复制形式。它也可以应用于任何具有产生平端的限制性内切酶独特位点的DNA序列。